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Abstract: In this work, racemic hybrid polypeptides poly(ethylene glycol) (PEG)-b-
poly(racemic-leucine) (PRL) copolymers with different leucine residues have been synthesized 
and characterized. Using docetaxel as a model molecule, the high drug-loaded spherical micelles 
based on PEG-PRL were prepared successfully using dialysis, with a tunable particle size from 
170 nm to 250 nm obtained by changing the length of the hydrophobic blocks. Facilitated drug-
loading behavior (higher drug-loading ability and easier drug-loading process) of PEG-PRL 
compared with their corresponding levo forms (PEG-b-poly[levo leucine]) was observed and 
clarified for the first time. With this facilitation, the highest drug-loading content and efficiency 
of PEG-PRL micelles can achieve 11.2% ± 0.4% and 67.2% ± 2.4%, respectively. All drug-
loaded PEG-PRL micelles exhibit a similar release behavior with a sustained release up to 72 
hours. The PEG-PRL was shown to be nontoxic against MCF-7 and human umbilical vein 
endothelial cells up to a concentration of 100 μg/mL, displaying a good biocompatibility. Also, 
the docetaxel-loaded PEG-PRL micelles were more toxic than the free drug against MCF-7 
human breast cancer cells – both dose and time dependent. Therefore, these high docetaxel-loaded 
micelles based on racemic hybrid polypeptides appear to be a novel promising nanomedicine 
for anticancer therapy.
Keywords: racemic polypeptides, micelles, conformation, high drug-loading ability, anticancer 
nanomedicine
Introduction
Polymeric micelles (PMs) based on amphiphilic block copolymers are one of the most 
promising nanodrug-delivery systems and have received much attention in recent years 
as anticancer drug carriers, due to their technical ease, high biocompatibility, and 
highly efficient drug delivery.1 Taking advantage of the classical core-shell structure 
and nanoscopic dimensions, PMs can protect fragile molecules in their hydrophobic 
core from being destroyed by environmental conditions and allow them to remain 
unrecognized by the reticuloendothelial system during blood circulation. This   facilitates 
their extravasations at leaky capillaries, known as the “enhanced permeability and 
retention effect,” leading to a passive accumulation in tumor tissues and, consequently, 
increased drug delivery efficiency.2
The synthetic flexibility and favorable physicochemical characteristics of the block 
copolymers also provide   additional advantages for the production of efficient micelles. 
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Although many types of amphiphilic block copolymers can 
form micelles, extensive studies have shown that the hybrid 
polypeptides of poly(ethylene glycol) (PEG)-b-poly(amino 
acids) copolymers are possibly the most suitable components 
for designing PMs,3,4 due to their excellent biocompatibility 
and various functional groups, such as carboxyl and amino, 
which can be easily tailored to allow drug incorporation or 
the production of versatile copolymers.
Generally speaking, published studies5–9 have mainly 
focused on poly(levo-amino acid) copolymers and their 
use in micelle construction because certain lengths of levo 
polypeptide sequences can adopt ordered conformations, 
such as α-helices or β-strands, which are believed to 
offer the benefit of an additional means of directing and 
stabilizing the formation of nanostructures.10 Following 
developments in this field, the racemic polypeptide 
sequences (poly[racemic-amino acid]) in amphiphilic 
copolymers have also been found to possess many unique 
characteristics. For example, Hanson et al11 reported that the 
use of racemic polypeptide sequences could prevent α-helix 
formation and increase chain flexibility, and the spherical 
micelles based on poly(Nε-2-[2-(2-methoxyethoxy)ethoxy]
acetyl-L-lysine)100-b-poly(racemic-leucine)10 copolymer 
showed excellent stability at elevated temperatures and under 
a variety of solution conditions. Choi et al12 reported the 
different gel-forming properties of the PEG-b-poly(racemic 
alanine) copolymer compared with its corresponding levo 
polypeptides. The unique role of poly(racemic-amino 
acids) segments in the formation of stable nanosized double 
emulsions was also found to involve increased solubility in 
the oil phase as well as an additional stabilizing effect by 
hydrogen bond formation compared with its levo forms.13
However, few investigations have focused on the self-
assembly behavior and the potential application as drug 
carriers of these racemic segment-based hybrid polypeptides, 
such as PEG-poly(racemic amino acid) copolymers. Also, 
very few investigations have compared the self-assembly 
behavior and drug-loading process of racemic polypeptide-
based polymers compared with their levo forms. Systematic 
and comprehensive investigations of racemic polypeptide 
segments in amphiphilic polymers are still needed to identify 
their role in nanostructure formation as well as to explore 
the potential applications of this nanostructure as a useful 
drug-delivery vehicle.
Therefore, in this study, PEG-poly(racemic leucine) 
copolymers with different amounts of leucine residues, as 
representatives of PEG-poly(racemic amino acid) hybrid 
polypeptides, were synthesized and characterized. Their 
self-assembly behavior and the potential application as 
anticancer drug carriers were studied using docetaxel (DTX) 
as a model drug, because DTX is a potent hydrophobic 
anticancer drug and its current commercially available 
formulations (containing large amounts of Tween 80) have 
serious deficiencies in terms of their physical instability and 
the toxicity of the vehicle.14 Although Abraxane® (the Food 
and Drug Administration-approved albumin nanoparticle-
bound PTX) partially resolved the toxic issues of Tween 80, 
it still tends to precipitate 24 hours after being reconstituted 
with saline.15 Moreover, the conformation-facilitated 
drug-loading behavior (a higher drug-loading ability and 
easier drug-loading process) of racemic hybrid polypeptide-
based copolymers compared with the corresponding levo 
forms (PEG-poly[levo leucine]) was observed for the 
first time, and the possible mechanisms of action were 
examined and discussed. These results should provide the 
basis for the further application of the PEG-poly(racemic 
amino acid) hybrid polypeptides as effective carriers for 
anticancer drugs.
Materials and methods
Materials
Alpha-methoxyl-ω-amino poly(ethylene glycol) hydrochloride 
(mPEG-NH2⋅HCl, Mn: 5392, polydispersity index: 1.04, 
JenKem Technology Ltd, Co, Beijing, People’s Republic of 
China) was dried in nitrogen for 24 hours before use; racemic 
leucine (rac-Leu, Sichuan Tongsheng Amino Acid Ltd, 
Co, Sichuan, People’s Republic of China) and triphosgene 
(99%; GL Biochem, Shanghai, People’s Republic of China) 
were recrystallized and dried in a vacuum for 24 hours before 
use; and DTX (Shanghai Sanwei Pharma Ltd, Co, Shanghai,   
People’s Republic of China) was used as received.
All organic solvents used in the synthesis experiments 
were purchased from National Medicine Chemical Reagent 
Ltd Co (Shanghai, People’s Republic of China) and pro-
cessed using the following method: ethyl acetate and dichlo-
romethane (DCM) were dried by refluxing over CaH2 and 
distilled prior to use, tetrahydrofuran (THF) and petroleum 
ether (boiling range 30°C–60°C) were dried and distilled 
from sodium immediately before use, and N,N′-dimethyl 
formamide (DMF) was used without further purification.
Dimethyl sulfoxide (DMSO), Dulbecco’s modified Eagle’s 
medium, RPMI 1640 medium, fetal bovine serum, penicillin-
streptomycin, trypsin, Dulbecco’s phosphate buffered saline, 
and 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide (MTT) were purchased from Gibco Company (New 
York, NY).
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The water used was double distilled. Acetonitrile and 
methanol were of chromatographic grade, other solvents 
were of analytical grade, and all other chemicals were of 
commercially available reagent grade.
Synthesis of racemic-N-carboxy-leucine 
anhydride
The racemic-N-carboxy-leucine anhydride (rac-Leu-NCA) 
was prepared according to the procedure published in 
the literature16 with some modification. Briefly, rac-Leu 
(10.0 g, 76.2 mmol) was suspended in 50 mL dry THF and 
heated to 55°C. After 30 minutes, a solution of triphosgene 
(8.0 g, 27.0 mmol) in 100 mL anhydrous THF was added 
dropwise under stirring, maintaining reaction until the 
mixture turned transparent (about 1.5 hours). Then, the 
reaction system was purged with nitrogen to eliminate 
chlorine hydride gas generated by the reaction for 30 minutes 
before totally evaporating the solvent under reduced 
pressure. The obtained crude crystals of rac-Leu-NCA were 
recrystallized three times from a mixture of ethyl acetate 
and petroleum ether at −20°C as white crystalline needles 
before use.
Synthesis of methoxyl poly(ethylene 
glycol)-poly(racemic-leucine) diblock 
copolymer
mPEG-poly(racemic-leucine) (PRL) diblock copolymer was 
synthesized via the ring-opening polymerization (ROP) of 
rac-Leu-NCA initiated by mPEG-NH2 ⋅ HCl in anhydrous 
DCM with different feed ratios. The reaction system was 
stirred in a nitrogen atmosphere at room temperature for 
72 hours. After washing twice with deionized water, the 
resulting mixture was evaporated under reduced pressure 
until a dry film was obtained, and DMF was then added to 
totally dissolve it. The solution was then transferred to a 
dialysis tube (cellulose ester, MWCO: 3500) and dialyzed 
with deionized water for 24 hours. The medium was replaced 
several times to completely remove the DMF. Finally, the 
fluffy white powder was collected by freeze-drying the 
  suspension within the dialysis tube.
Polymer characterization
1H-nuclear magnetic resonance (NMR) spectra of all 
  samples were measured on a Bruker DMX 300 spectrometer   
(Billerica, MA). Chemical shifts (δ) were given in ppm 
using tetramethylsilane as the internal standard. Fourier 
transform infrared spectroscopy spectra were recorded on a 
Bruker Tensor 27 spectrometer, and samples were prepared 
using KBr disks (Scharlau Chemie, Barcelona, Spain). Gel 
permeation chromatography (GPC) assay was performed on 
a Waters 1515 GPC instrument (Waters Corp, Milford, MA) 
equipped with three Styragel columns (Waters Corp; 105, 
104, and 103 Å) in tandem and a 2414 differential refractive 
index detector. DMF (containing 0.1 M LiBr) was selected 
as the eluent at a flow rate of 1.0 mL/minute at 35°C, and 
the sample concentrations were approximately 2 mg/mL. 
The molecular weights were calibrated using polystyrene 
standards.
Optical rotations were determined on a PerkinElmer 241 
MC polarimeter (Waltham, MA) equipped with a 1 dm quartz 
cell at the sodium D-line wavelength (25°C, in absolute THF). 
The specific optical rotation  α [] D
25 was calculated from the 
following formula:17
  α []=
D
r
lc
25
where r is the angle of rotation, l the number of decimeters 
of solution, and c the sample concentration (g/mL).
Determination of the critical aggregation 
concentration
The critical aggregation concentration (CAC) of the 
amphiphilic PEG-PRL diblock copolymer was determined 
by the classical “pyrene fluorescence probe” method 
published elsewhere.18 Specifically, 100 µL of pyrene solu-
tions (1 × 10−5 M in acetone) was transferred to a series 
of 10 mL volumetric flasks, then acetone was completely 
volatilized under a gentle stream of nitrogen. A series of 
aqueous copolymer solutions were added to the acetone-
free pyrene flasks and made up to the mark with deionized 
water, yielding final pyrene and copolymer concentrations 
of 1 × 10−7 M and 1 × 10−5 to 0.1 mg/mL, respectively. The 
resulting solutions were sonicated in an ultrasonic bath at 
180 W for 30 minutes and equilibrated overnight at room 
temperature. The fluorescence excitation spectra of pyrene 
from 300 to 350 nm of pyrene were recorded on an F-7000 
fluorescence spectrophotometer (Hitachi, Tokyo, Japan) by 
fixing the emission wavelength at 390 nm and setting the 
slit widths for emission and excitation at 2.5 and 5.0 nm, 
respectively. Spectra were accumulated with a scan speed of 
240 nm/minute. The fluorescence intensity ratio at 337 and 
334 nm (l337/l334) of pyrene versus the logarithm of the poly-
mer concentration was plotted from the excitation spectra, 
and the CAC was obtained from the inflection point of this 
plot. All samples were measured in parallel.
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Micelle preparation
DTX-loaded micelles were prepared by dialysis method. 
Briefly, DTX (2 mg) and copolymer (10 mg) were completely 
dissolved in 2 mL DMF, and then aliquots of phosphate-
buffered saline (PBS; 10 mM, pH5.5) were added dropwise 
to the solution using a syringe under continuous stirring. 
The obtained dispersion was stirred for several hours, 
  followed by dialyzing with 500 mL PBS (10 mM, pH5.5) 
for 24 hours, replacing the outer medium three times (2, 6, 
and 12 hours) and using a cellulose ester dialysis membrane 
with a molecular cut-off of 14,000. Finally, the mixture was 
filtered through a 0.45 µm filter to remove precipitate, and 
the DTX-loaded micelles were obtained.
High-performance liquid chromatography 
analysis
DTX concentrations were determined by high-performance 
liquid chromatography (HPLC) (Hitachi L-2130 pump, Hitachi 
L-2400 UV-Vis detector) at a wavelength of 230 nm, using 
a Diamonsil C18 column (5 µm, 250 × 4.6 mm). A mobile 
phase of acetonitrile and water (70/30, v/v) was selected for 
the separation, and the flow rate was set at 1 mL/minute.   
The peak area response versus the DTX concentration was 
linear over the range 0.5–30 µg/mL (r2 = 0.9999).
Determination of drug-loading ability
The drug-loading ability of the DTX-loaded micelles was 
determined by HPLC. Briefly, 100 µL DTX-loaded micellar 
solution and 1 mL of THF were transferred to a 10 mL 
  volumetric flask. The flask was placed in an   ultrasonic bath 
and sonicated at 180 W for 10 minutes, then diluted with 
methanol and mixed thoroughly. The resulting solution 
was analyzed using the validated HPLC method described 
  previously. The drug-loading content (DLC) and   drug-loading 
efficiency (DLE) were calculated using the following 
equations:
 
Drug-loadingconcent=
weightof DTXinmicelles
weightof drug-loade edmicelles
100%
 
Drug-loadingefficiency =
weightof DTXinmicelles
weightof DTXfeed ding
100%
The “weight of DTX in micelles” was calculated by the 
product of the DTX concentration measured by HPLC and 
the micellar volume. The “weight of drug-loaded micelles” 
was the total weight of the polymer and drug fed into the 
micelle preparation.
Particle size measurements
The particle size and distribution of micelles were measured 
by dynamic laser light scattering (DLS) with NICOMPTM 
380 Submicron Particle Sizer (Particle Sizing Systems, 
Santa Barbara, CA) at room temperature. A laser beam at a 
wavelength of 632.8 nm was used, and the scattering angle 
was set to 90° when measurements were conducted.
Morphological analysis
The morphology of micelles was observed using transmission 
electron microscopy (TEM) and scanning electron 
  microscopy (SEM).
Samples for TEM observations were prepared by   placing 
one drop of sample solution (0.5 mg/mL for copolymer) 
on to a copper grid coated with carbon. Excess solution 
was wiped away with the aid of filter paper, and the grid 
was allowed to dry for a further 10 minutes. Then, the samples 
were   examined using a Hitachi H-600 TEM operated at an 
  accelerating voltage of 100 kV .
Samples for SEM observations were prepared by   dusting 
the lyophilized micellar powder on to double-adhesive con-
ductive tape, which had been applied previously to a copper 
stub. After coating with a 30 nm thin layer of gold/palladium, 
the samples were observed using a Shimadzu SSX-500 field 
emission SEM (Tokyo, Japan) operating at an acceleration 
voltage of 10 kV .
Conformation analysis
Circular dichroism was used to analyze the conformation of 
the polypeptide blocks using a JASCO J-810 spectrometer 
(Tokyo, Japan). Hybrid polypeptides (0.01 mg/mL in deion-
ized water) were introduced into quartz cells with a 1 cm 
optical path length and measured at room temperature.
In vitro release studies
The in vitro release behavior of DTX from various 
preparations was investigated by dialysis diffusion method.19 
Specifically, a drug-loaded micellar solution or free drug 
solution (Taxotere®; Sanofi-Aventis, Paris, France) containing 
about 100 µg DTX was transferred to a preswelled dialysis 
tube (cellulose ester, MWCO: 14,000). The tube was then 
incubated in 10 mL PBS (10 mM, pH7.4) containing 0.1% 
w/v Tween 80 to achieve sink conditions, and placed in a 
horizontal water bath shaker maintained at 37°C ± 0.5°C 
with a shaking speed of 100 rpm. At predetermined intervals, 
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the dialysis tube was removed and placed in a new container 
filled with 10 mL fresh medium. The collected incubation 
media were analyzed by HPLC. All data were obtained in 
triplicate using parallel experiments and were expressed as 
mean values.
In vitro cytotoxicity studies
Cell culture
Human umbilical vein endothelial cells (HUVECs) 
and MCF-7 human breast cancer cells were generously 
  provided by the Cell Center of the Chinese Medical 
University. HUVECs were cultured in RPMI 1640 medium, 
and MCF-7 cells were cultured in Dulbecco’s modified 
Eagle’s medium, both supplemented with 10% (v/v) 
fetal bovine serum and 1% (v/v) penicillin-streptomycin 
(100 U/mL   penicillin and 100 µg/mL streptomycin) at 37°C 
in a humidified atmosphere with 5% CO2. The cells were 
  harvested with 0.25% trypsin and 0.5 mM EDTA and rinsed. 
The resulting cell suspensions were used in the following 
experiments.
Cell viability test
The cytotoxicity of PEG-PRL copolymer, DTX, and DTX-
loaded micelles was evaluated in MCF-7 and/or HUVECs 
using the MTT assay.20 Briefly, cells were seeded in 96-well 
plates at a density of 104 cells per well. Following a 24-hour 
incubation to allow cell attachment, the growth medium was 
removed and replaced with 100 µL fresh medium containing 
different amounts of PEG-PRL, free DTX, or DTX-loaded 
micelles (n = 5). The micelles were sterilized with ultraviolet 
irradiation for 1 day prior to use. After predetermined periods 
of incubation, 20 µL MTT (5 mg/mL in PBS) was added 
to each well and incubated for another 4 hours. The cul-
ture medium was withdrawn, and formazan crystals were 
  dissolved in 100 µL DMSO. The optical density (OD) of the 
resulting solution was then read at 490 nm using an ETY96 
ELISA Reader (Toyo-Sokuki Inc, Tokyo, Japan). Cell viabil-
ity was calculated from the following equation:21
  Cellviability(%) =
−
−
×
OD OD
OD OD
treatedb lank
controlb lank
100%
where ODtreated is the OD value of the cells treated with the 
samples, ODcontrol is the OD value of the cells treated with 
PBS alone, and ODblank is the OD value of the blank solution. 
IC50, the drug concentration at which 50% inhibition of cell 
growth occurred, was extrapolated from the dose response 
curves and reported in terms of DTX equivalents.
Statistical analysis
All data were presented as mean ± standard deviation and 
analyzed using Student’s t-test. Statistical significance 
was determined at a value of P , 0.05 except for special 
declaration.
Results and discussion
Synthesis and characterization 
of methoxyl polyethylene glycol-
poly(racemic-leucine) copolymer
The ROP of amino acid N-carboxy-anhydrides (NCA) is still 
the most commonly used technique to synthesize polypeptides, 
because of its simplicity and ease of product purification,22 
although some limitations of this anionic polymerization 
have been reported, such as the low reaction efficiency and 
broad molecular weight distribution of the resulting product 
due to incidental side reactions.23 To improve the quality of 
this traditional reaction, several considerations have been 
taken into account in this experiment, in addition to the 
special care needed for purifying the solvents and reagents 
used. Firstly, all synthesis operations were carried out using 
a Schlenk line. The hydrochloride of amino-terminated PEG 
(mPEG-NH2 ⋅ HCl) was then selected as the macroinitiator 
because the hydrochloride molecule can effectively prevent 
side reactions by providing a proton and avoiding chain 
growth via the “activated monomer” mechanism.24 Finally, 
the racemic-Leucine-NCA (rac-Leu-NCA) was synthesized 
directly from racemic leucine to simplify operations and 
improve the quality of NCA instead of using the existing 
method,11,13 which involves synthesizing the dextro-leucine-
NCA and levo-leucine-NCA monomer in separate steps and 
mixing them equivalently as racemic forms.
Based on the modified reaction procedure (Scheme 1),   
three PEG-PRL copolymers with different molecular weights 
were obtained by varying the NCA/initiator molar feed ratios. 
The chemical structures of the products were confirmed 
by examination of the  1H-NMR and infrared   spectra. It 
is illustrated in Figure 1 that the peaks at 1816 cm−1 and 
1754 cm−1 are attributed to the C=O stretching vibration 
in the anhydride. Their disappearance, together with the 
emergence of an amide I and amide II bond at 1660 cm−1 
and 1547 cm−1 in the PEG-PRL Fourier transform infrared 
spectroscopy spectra, proved the successful synthesis of the 
polypeptides. In addition, the marked peak at 1109 cm−1 is 
attributed to the C-O-C stretching vibration in the PEG 
block. The position, number, and splitting behavior of the 
NMR peaks coincide well with the structure of NCA with 
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a smooth baseline, as shown in Figure 2, confirming the 
purity and uniformity of the synthesized NCA monomer. 
In the case of the PEG-PRL NMR spectrum, the chemical 
shifts at 3.64 ppm and 0.91 ppm are assigned to protons of 
-CH2- in the PEG units and protons of (CH3)2- in the leu-
cine residues, respectively. These two peaks were also used 
to calculate the molecular weight of the polymers because 
they appeared with good reproducibility and without any 
signs of interference.
As listed in Table 1, the molecular weights of the PEG-
PRL polymers calculated by 1H-NMR were in proportion 
to the feed ratios of the monomer/initiator with an initiator 
efficiency not less than 0.6. Therefore, the constitution 
of the polymer could be tuned via the feed ratios and 
conveniently based on this synthesis method with proper 
initiator efficiency.
Because the GPC experiments were performed using 
a traditional refractive index detector and polystyrene 
samples as calibration standards, they were not expected to 
provide useful quantitative molecular weight information, 
partly because of the significant difference in the molecular 
structure between the samples and the standards.25 The GPC 
results, however, are useful for verifying the absence of 
homopolymer impurities and provide an index to evaluate the 
molecular weight distribution of the products. As shown in 
Figure 3, GPC traces of PEG-PRL copolymers showed a uni-
modal molecular weight distribution without homopolymers. 
The polydispersity index of the three polymer products 
4000 3000 2000 1500
Amide I
Amide II
C-O-C
C=O of anhydride
Wavenumber (cm−1)
T
r
a
n
s
m
i
t
t
a
n
c
e
1000 500
A
B
Figure 1 The representative Fourier transform infrared spectroscopy spectra of: rac-Leu-NCA (A) and PEG-PRL copolymer (B). 
Abbreviations: NCA, N-carboxy-anhydrides; PEG, poly(ethylene glycol); PRL, poly(racemic-leucine).
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Scheme 1 Synthesis routes of PEG-PRL copolymers. 
Abbreviations: DCM, dichloromethane; NCA, N-carboxy-anhydrides; PEG, poly(ethylene glycol); PRL, poly(racemic-leucine); rac-Leu, racemic-leucine; THF, tetrahydrofuran.
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was always below 1.1, estimated from the GPC and listed 
in Table 1, which illustrates the low molecular weight 
distribution of the resulting polymers.
The optical activities of the PEG-PRL copolymers were 
analyzed by polarimetry to estimate the racemic extent of the 
polypeptide segments. The specific optical rotations  α [] D
25 
of the three products were all very small and negligible, as 
listed in Table 1, confirming the successful preparation of 
the racemic polypeptide block in the copolymers.
Self-assembly ability of PEG-PRL 
copolymers
As amphiphilic polymers, the PEG-PRL products have 
the ability to self-assemble in selective solvents, which is 
the basis of their application as carriers for the delivery of 
hydrophobic drugs.
The CAC was determined to evaluate this ability using 
the “pyrene fluorescence probe” method. As demonstrated 
in Figure 4 (inset), the maximum excitation wavelength of 
pyrene increased from 334 nm to 337 nm with an increase 
in the PEG-PRL concentration. Therefore, the fluorescence 
intensity ratio at 337 nm and 334 nm (l337/l334) of pyrene 
versus the logarithm of the polymer concentration was 
plotted from the excitation spectra (Figure 4). The inflection 
point in this plot represented the formation of micelles, and 
the corresponding concentration was recorded as the CAC 
of the polymer. The CAC values of the three PEG-PRL 
polymers, calculated and listed in Table 1, ranged from 
1.1 to 6.5 mg/L, depending on the length of the hydrophobic 
polypeptide   segments. It appeared that the greater the length 
of the hydrophobic block, the lower the CAC value. This 
indicates a stronger self-assembly and may confer greater 
thermodynamic stability on the resulting micelles.26 The 
extremely low CAC values of all the synthesized PEG-PRL 
copolymers compared with the low molecular weight 
surfactants also offer the possibility of retaining micellar 
stability under diluted conditions, such as diluted by blood 
plasma after intravenous injection, which is a very favorable 
characteristic for the development of effective drug-delivery 
systems.
Table 1 Feed compositions and some characteristic properties of hybrid polypeptide copolymers
Sample Feed ratioa Mn (Da) DPb Initiator  
efficiencyc
Polydispersityd 
(MW/Mn) α α [] D
25 CAC 
(mg/L)
PEG-PRL1 20 7200 16 0.80 1.03 −1.6 6.5
PEG-PRL2 40 8150 24 0.60 1.05 +0.6 3.9
PEG-PRL3 60 9687 38 0.63 1.06 −1.6 1.1
PEG-PLL 60 10347 44 0.73 N/A N/A 0.8
Notes: aCalculated by nNCA/nPEG-NH2⋅HCL; brefers to degree of polymerization and calculated by 1H-NMR; ccalculated by DPcalculated/DPtargeted; dmeasured by GPC. 
Abbreviations: CAC, critical aggregation concentration; GPC, gel permeation chromatography; N/A, not analyzed; NMR, nuclear magnetic resonance; PEG, poly(ethylene 
glycol); PLL, poly(levo-leucine); PRL, poly(racemic-leucine).
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Figure 2 The representative 1H-NMR spectra of rac-Leu-NCA (A) and PEG-PRL copolymer (B) in CDCl3. 
Abbreviations: NCA, N-carboxy-anhydrides; NMR, nuclear magnetic resonance; rac-Leu, racemic-leucine; PEG, poly(ethylene glycol); PRL, poly(racemic-leucine).
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Preparation of DTX-loaded micelles
As one of the most commonly used methods of micellar 
preparation, the dialysis method was selected to prepare DTX-
loaded micelles in the current study. PBS with a pH of 5.5 was 
selected as the dispersion medium for the micellar formulations 
to increase DTX stability.27 Using this method, DTX-loaded 
micelles based on PEG hybrid polypeptides were prepared 
  successfully. Some characteristics of these micelles – namely, 
the particle size and size distribution determined by DLS, DLC, 
and DLE measured by HPLC – are summarized in Table 2.
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The DLS results showed that the micelles based on PEG 
hybrid polypeptides in aqueous solution were all nanosized 
particles with a narrow dispersion. For PEG-PRL micelles, 
the intensity-averaged diameters increased from about 170 to 
250 nm, depending on the length of the polypeptide   segments. 
Regarding the well-known core-shell structure of the 
micelles, this phenomenon could be explained by the volume 
expansion of the micellar hydrophobic core, which resulted 
from the longer hydrophobic chains constituted and more 
hydrophobic drug molecules encapsulated. As well as the 
increase in particle size, the DLC and DLE also increased 
with the molecular weight growth of the copolymer.
The representative DLS graphs and corresponding TEM 
photographs of blank and DTX-loaded micelles prepared 
based on PEG-PRL3 copolymer are shown in Figures 5 and 6. 
A classical core-shell structure with a spherical appearance 
was observed in the TEM photographs.
Furthermore, the diameter of the micelles increased almost 
two-fold after loading with DTX, from about 70 to 150 nm. 
This obvious expansion probably resulted from the incorpo-
ration of drug molecules, revealing the malleable character-
istic of the micelle core, the dimensions of which can vary 
during the drug-loading process. Under all circumstances, 
DLS measurement showed a larger diameter than the TEM 
determination, probably because of dehydration of micelles 
and shrinkage of the PEG shell induced by water evaporation 
under the high vacuum before TEM observation.28 The SEM 
photographs of the DTX-loaded PEG-PRL micelles further 
proved the spherical shape and showed a similar diameter 
to that of TEM, as shown in Figure 7.
The highest drug-loading content and efficiency was 
found for the micelles based on the PEG-PRL3   copolymer, 
which possesses 38 leucine residues, with a value of 
11.2% ± 0.4% and 67.2% ± 2.4%, respectively. Both values 
were much higher than those of drug-loaded micelles, based 
on the previously published data on the corresponding levo 
polypeptides. The poly(levo-leucine)-PEG5000-poly(levo- 
leucine) triblock copolymers with a total of 120 leucine 
residues synthesized by Hua et al29 were used to prepare PTX-
loaded spherical micelles. The obtained DLC and DLE for 
PTX, which also belongs to the taxoid family and has a simi-
lar molecular structure to DTX, were only 5.5% and 11.7%, 
respectively. With the length of the hydrophobic chains being 
three times greater than a PEG-PRL3 copolymer, the levo 
polypeptides reached only half the drug-loading capacity 
of the racemic polypeptides. This apparent difference in 
drug loading between the two polypeptides hinted that the 
conformation of the hydrophobic peptide block may play an 
important role in the drug-loading process. Because it is well 
known that poly(levo amino acids) chains may adopt a special 
conformation, such as α-helices or β-strands,12 this contrasts 
with the random coil conformation of racemic chains.
To further verify this conformation-determined drug-
loading behavior, the PEG5000-poly(levo-leucine) diblock 
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Figure 5 The representative dynamic laser light scattering graphs of blank (A) and docetaxel-loaded (B) PEG-PRL3 micelles. 
Abbreviations: PEG, poly(ethylene glycol); PRL, poly(racemic-leucine).
Table 2 Characteristics of various docetaxel-loaded micelles
Polymer Size (nm) Polydispersity  
index
DLC (%) DLE (%)
PEG-PRL1 174.0 ± 2.4 0.219 ± 0.062   5.5 ± 0.8 33.0 ± 4.8
PEG-PRL2 206.0 ± 2.3 0.184 ± 0.025   7.5 ± 0.6 44.8 ± 3.7
PEG-PRL3 256.1 ± 10.7 0.179 ± 0.032 11.2 ± 0.4 67.2 ± 2.4
PEG-PLL 159.0 ± 4.3 0.102 ± 0.073 0.32 ± 0.1   1.3 ± 0.7
Note: Data represent mean ± standard deviation (n = 3). 
Abbreviations: DLC, drug-loading content; DLE, drug-loading efficiency; PEG, poly 
(ethylene glycol); PLL, poly(levo-leucine); PRL, poly(racemic-leucine).
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
117
Novel anticancer polymeric micellesInternational Journal of Nanomedicine 2012:7
copolymer (PEG-PLL) with 44 leucine residues (calculated 
by NMR) was synthesized using the ROP of levo-leucine-
NCA similar to the synthesis of PEG-PRL. The CAC of 
the polymer, measured by the aforementioned fluorescence 
method, was 0.8 mg/L (Table 1). This was not significantly 
different from the CAC value of the PEG-PRL3 polymer 
(1.1 mg/mL) and demonstrated the strong self-assembly 
ability of the levo polypeptides.
The TEM photographs of blank and DTX-loaded PEG-
PLL micelles prepared by the dialysis method are shown in 
Figure 8. It is clear that the morphology and particle size 
of the blank PEG-PLL micelles (Figure 8A) are all similar 
to those of the PEG-PRL3 blank micelles (Figure 6A), 
indicating that the levo polypeptides also have the ability to 
self-aggregate into spherical micelles in aqueous solution. 
Unlike the significant volume expansion (nearly two-fold, 
Figure 6B) after loading with DTX for PEG-PRL3 micelles, 
the diameter of PEG-PLL micelles exhibited no apparent 
change after DTX loading (Figure 8B), which confirmed 
the relatively rigid structure of the micellar core based on 
levo polypeptides compared with their racemic counterparts. 
As shown in Table 2, the DLC and DLE of DTX-loaded   
PEG-PLL micelles measured by HPLC were around 0.3% 
and 1.3%, respectively. These values were far lower than 
those of all the PEG-PRL micelles, which further confirmed 
the significant discrepancy in drug-loading ability between the   
racemic and levo polypeptides.
To obtain a better understanding of this phenomenon, 
circular dichroism was used to study the secondary struc-
ture of the different polypeptides. In the circular dichro-
ism spectrum presented in Figure 9, the PEG-PLL sample 
showed two negative bands at 208 and 222 nm, which can 
be assigned to π–π*and n–π* transitions due to Cotton effects 
and correspond to an α-helical conformation of the peptide 
chain,30 whereas in all the PEG-PRL samples, no secondary 
structure conformation was detected.
Based on this observation, the different drug-loading 
ability of the PEG-PLL and PEG-PRL micelles could be 
explained. On the one hand, as presented in Scheme 2, 
the PLL block in the PEG-PLL copolymer preferentially 
adopted a stable α-helical conformation and was packed 
to form a rigid and compact hydrophobic core of spherical 
Figure 7 The representative scanning electron microscopy photograph of lyophilized 
docetaxel-loaded PEG-PRL3 micelles. 
Abbreviations: PEG, poly(ethylene glycol); PRL, poly(racemic-leucine).
AB
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Figure 6 The representative transmission electron microscopy photographs of 
blank (A) and docetaxel-loaded (B) PEG-PRL3 micelles. 
Abbreviations: PEG, poly(ethylene glycol); PRL, poly(racemic-leucine).
AB
100 nm 100 nm
Figure 8 The transmission electron microscopy photographs of blank (A) and 
docetaxel-loaded (B) PEG-PLL micelles. 
Abbreviations: PEG, poly(ethylene glycol); PLL, poly(levo-leucine).
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Figure 9 The CD spectrum of various copolymers in aqueous solution (0.01 mg/mL). 
Abbreviations: CD, circular dichroism; PEG, poly(ethylene glycol); PLL, poly(levo-
leucine); PRL, poly(racemic-leucine).
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micelles, leaving a limited and restricted space for loading 
drug molecules. However, in the case of PEG-PRL, the PRL 
block had no specific conformation and was coiled to form 
a relatively malleable and loose hydrophobic core, which 
could encapsulate many more drug molecules compared with 
PEG-PLL. On the other hand, compared with the α-helix 
conformation of PLL, the random coil of the PRL block 
has more freely exposed amide groups that are capable of 
facilitating H-bonding interactions between hydrophobic 
chains or hydrophobic chains and drug molecules in the 
assemblies,11 which would also cause additional entrapment 
of DTX molecules and provide extra micelle stability simply 
through a physical interaction. Therefore, it is proposed that 
both the hydrophobic interactions and the secondary struc-
tures of the polypeptide domains control the drug-loading 
behavior of the PEG-poly(leucine) hybrid polypeptides, and 
the racemic polypeptides are capable of a much higher drug-
loading capacity than the levo forms.
In addition, during the process of micellar preparation, 
a significant difference in solubility between PEG-PLL 
and PEG-PRL copolymers was observed. The PEG-PRL 
copolymer could dissolve easily in many common organic 
solvents, including acetone, chloroform, DCM, THF, DMF, 
and DMSO, whereas the PEG-PLL copolymer could only 
dissolve in strongly H-bonding solvents such as trifluoroa-
cetic acid. The better solubility of PEG-PRL compared with 
its levo form can be ascribed to the conformation difference, 
because the random coil conformation of the PRL block 
offers much more flexibility compared with the rigid α-helix 
conformation of PLL segments, as also reported elsewhere.11 
This conformation, resulting in better solubility of PEG-PRL, 
also facilitated the DTX-loading behavior by providing an 
easier drug-loading process. In fact, the better solubility of 
the PEG-PRL copolymer is more favorable in the process 
of drug development by providing a more flexible formula 
and preparation technique, according to the characteristics 
of the drug chosen for loading and avoiding the application 
of toxic solvents such as trifluoroacetic acid.
In summary, the racemic hybrid polypeptides (PEG-PRL) 
facilitated the doxetaxol-loading behavior by providing a much 
higher drug-loading ability and easier drug-loading process 
compared with the corresponding levo forms (PEG-PLL).
In vitro release studies
The in vitro release behavior of DTX-loaded PEG-PRL and 
PEG-PLL micelles was investigated by dialysis diffusion 
method.19
As shown in Figure 10, a similar typical biphasic release 
pattern, composed of a burst release in the initial stage 
  followed by a sustained release up to 72 hours, was observed 
under all the PEG-PRL conditions, indicating that the 
release behavior of DTX from racemic polypeptide-based 
micelles depends little on the length of the hydrophobic 
Self-aggregate
Self-aggregate
PEG-PLL
Drug molecules
PEG-PRL
Scheme 2 Schematic representation showing the drug-loading process and self-assembly structure of micelles based on PEG-PLL and PEG-PRL copolymers. 
Abbreviations: PEG, poly(ethylene glycol); PLL, poly(levo-leucine); PRL, poly(racemic-leucine).
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Figure 10 In vitro DTX release behavior of DTX-loaded micelles and Taxotere® 
(n = 3). 
Abbreviations: DTX, docetaxel; PEG, poly(ethylene glycol); PLL, poly(levo-leucine); 
PRL, poly(racemic-leucine).
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block. An obvious difference between the release curve of 
PEG-PRL micelles and Taxotere was also observed with a 
more rapid release of DTX from Taxotere, demonstrating 
the sustained release properties of the PEG-PRL micelles. 
Furthermore, it was found that the release rate of PEG-PLL 
micelles was much slower than others, which released less 
than 40% of the loaded drug during the entire experimental 
period. This difference in release behavior between the 
micelles based on PEG-PLL and PEG-PRL copolymer 
further proved the different state of the hydrophobic core 
presented in Scheme 2. This is because the drug molecules 
can be released from the loose core formed by the racemic 
polypeptides more easily than from the compact core formed 
by levo polypeptides.
Cell cytotoxicity studies
Because the highest drug-loading content and efficiency were 
found in the PEG-PRL3 micelles, these micelles and the 
PEG-PRL3 copolymer were selected for further studies.
As a potential drug-loading carrier, the material used 
must be proved to be nontoxic to humans (ie, it should be 
highly biocompatible). Therefore, the in vitro cytotoxicity 
of the PEG-PRL3 copolymer was studied with MCF-7 and 
HUVECs to evaluate the biocompatibility of the racemic 
polypeptides using MTT assay.
As shown in Figure 11, the cell viability in the   presence 
of various concentrations of PEG-PRL3 copolymer was in the 
range of 99.3% ± 1.7% to 102.5% ± 4.1% for MCF-7 cells 
and 99.0% ± 1.8% to 103.7% ± 2.7% for HUVECs. This 
result proved that PEG-PRL3 copolymer exhibited almost 
no cytotoxicity against these two kinds of cells up to the 
concentration of 100 µg/mL, demonstrating the excellent 
biocompatibility of PEG-PRL copolymer.
The in vitro cytotoxicity of the DTX-loaded PEG-
PRL3 micelles was also studied by MTT using MCF-7 cells 
to evaluate the antitumor effect of the drug-loaded micelles 
against tumor cells. In this study, a DMSO solution of DTX 
was used as the free drug stock solution instead of commer-
cially available DTX preparations such as Taxotere, because 
of the known cytotoxity of Tween 80, which is used as a 
surfactant at a high concentration in these preparations.31,32
The MCF-7 cell viability after 72 hours of incubation 
with various concentrations of free DTX and DTX-loaded 
micelles is shown in Figure 12. In general, the viability of 
cells incubated with the two preparations decreased in a 
dose-dependent fashion. Furthermore, a much lower cell 
viability (P , 0.01) of micelles compared with free drug 
was observed at all concentrations, and the IC50 of the free 
DTX and DTX-loaded micelles was 0.036 (Emax: 77.7%) and 
0.009 µM (Emax: 84.8%), respectively. This result suggests 
that the DTX-loaded micelles are more cytotoxic than the 
free drug against cancer cells, which is probably because 
the additional drug internalized in the cells resulted from 
endocytosis and enhanced intracellular drug accumulation 
by the nanoparticle uptake reported elsewhere.33,34
The MCF-7 cell viability after incubation with the free 
DTX and DTX-loaded micelles at the same concentration (10 
µM calculated by DTX) after 24 hours, 48 hours, 72 hours, 
and 96 hours is shown in Figure 13. With prolongation of 
the incubation time, a gradual decrease in cell viability 
was observed in the DTX-loaded micelles. However, the 
cell viability of free DTX at 72 hours and 96 hours was 
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Figure 11 In vitro cytotoxicity of different concentrations of PEG-PRL3 copolymer 
against HUVECs and MCF-7 cells by MTT assay (n = 5). 
Abbreviations:  DTX,  docetaxel;  HUVECs,  human  umbilical  vein  endothelial 
cells;  MTT,  3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium  bromide;  PEG, 
poly(ethylene glycol); PRL, poly(racemic-leucine).
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Figure  12  In  vitro  cytotoxicity  of  different  concentrations  of  free  drug  and 
docetaxel-loaded PEG-PRL3 micelles against MCF-7 cells by MTT assay (n = 5). 
Note: *P , 0.01. 
Abbreviations: MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; 
PEG, poly(ethylene glycol); PRL, poly(racemic-leucine).
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not significantly different (P . 0.05), with a value of 
18.1% ± 1.7% and 19.8% ± 0.7%, respectively, in contrast 
to the significantly different cell viability (P , 0.01) of 
DTX-loaded micelles at 72 hours and 96 hours with a value 
of 21.2% ± 1.3% and 15.4% ± 0.6%, respectively. This 
  suggests that the incubation time of 72 hours may be critical 
to allow the free DTX to kill MCF-7 cells, although this time 
threshold must be much longer for DTX-loaded micelles. 
This phenomenon can be attributed to the sustained release 
of DTX from the micelles, as already proved by the in vitro 
release studies.
Conclusion
In summary, racemic hybrid polypeptides, PEG-PRL 
diblock copolymers, with different lengths of hydrophobic 
segments were synthesized. Based on the micellization 
of these amphiphilic copolymers in aqueous solution, the 
antitumor drug DTX could be entrapped successfully with 
high drug-loading capacity. In contrast to the corresponding 
levo polypeptide PEG-PLL, the random coil conformation 
of racemic polypeptides PEG-PRL facilitated drug-loading 
due to the looser hydrophobic micelle core, more H-bonding 
interactions, and much more chain flexibility. This allowed 
encapsulation of more drug molecules in an easier way. 
According to the cytotoxicity assay, the hybrid racemic poly-
peptide PEG-PRL used as a drug carrier was nontoxic against 
MCF-7 and HUVECs up to a concentration of 100 µg/mL. 
Also, the anticancer efficacy of the DTX-loaded micelles was 
much higher than that of the free drug against MCF-7 cancer 
cells. These results unequivocally demonstrated that these 
high drug-loading PMs based on hybrid racemic polypeptides 
may be used as a more effective drug vehicle than their levo 
forms for the delivery of lipophilic antitumor drugs.
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